SCHEMBL20105596

SCHEMBL20105596

C[C@@H]1OCCN[C@@H]1c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.61
ADRA1A P35348 1/20 0.61
HTR2B P41595 1/20 0.61
SLC6A3 Q01959 1/20 0.61
TACR1 P25103 7/20 0.46
CHRNA7 P36544 2/20 0.44
CYP2C19 P33261 2/20 0.39
HTR1A P08908 1/20 0.39
SLC18A3 Q16572 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GBA1 P04062 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11141618 1.00 SLC6A2 (0.61) SLC6A2ADRA1AHTR2BSLC6A3TACR1
Hydrochloric Acid SCHEMBL15922321 0.98 SLC6A2 (0.59) SLC6A2ADRA1AHTR2BSLC6A3TACR1
Hydrochloric Acid SCHEMBL15921749 0.98 SLC6A2 (0.59) SLC6A2ADRA1AHTR2BSLC6A3TACR1
Hydrochloric Acid SCHEMBL15921747 0.98 SLC6A2 (0.59) SLC6A2ADRA1AHTR2BSLC6A3TACR1
SCHEMBL27367888 0.82 CHRNA7 (0.41) SLC6A2ADRA1AHTR2BSLC6A3TACR1
SCHEMBL1333875 0.81 SLC6A2 (0.65) SLC6A2ADRA1AHTR2BSLC6A3TACR1
SCHEMBL24005933 0.77 SLC6A2 (0.44) SLC6A2ADRA1AHTR2BSLC6A3CHRNA7
Phenmetrazine SCHEMBL15159760 0.76 SLC6A2 (1.00) SLC6A2ADRA1AHTR2BSLC6A3TACR1
Phenmetrazine SCHEMBL15154744 0.76 SLC6A2 (1.00) SLC6A2ADRA1AHTR2BSLC6A3TACR1
Phenmetrazine SCHEMBL8094204 0.76 SLC6A2 (1.00) SLC6A2ADRA1AHTR2BSLC6A3TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951180-B1 2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS MERCK SHARP & DOHME (US) 2018-05-02 EP disclosed